Alexander Aust, MS, MBA

CMC, manufacturing, and GMP-quality leader with 13+ years of hands-on operating depth across QC microbiology, validation, quality assurance, business development, and CDMO operations, now translated into a full-service consulting practice.

Manufacturing-modality expertise spans plasmid DNA, monoclonal antibodies, mRNA, LNP, and aseptic fill/finish, with active work in cell and gene therapy facility design, construction, and operations. Already an active Intelisci SAB member since September 2023, plus Venture Partner at LemVega Capital and recent Senior Advisor work in the Middle East (Qatar).

Brings operator-grade detail on the CMC, regulatory, and manufacturing-readiness questions that derail many early- and mid-stage biotech programs.